We enrolled two wild‐type (WT) healthy volunteers who had not been diagnosed with a central nervous system disease, and 2 PD patients who had the LRRK2 G2019S mutation verified (Figure 1A). The gene discussed is LRRK2; the disease is central nervous system disorder.